89.80
-0.40
(-0.44%)
At close: January 10 at 4:00:21 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-49,419.00
-49,419.00
24,340.00
88,513.00
32,987.00
Investing Cash Flow
-351,388.00
-351,388.00
44,054.00
-27,179.00
-7,199.00
Financing Cash Flow
382,789.00
382,789.00
-112,254.00
-12,648.00
905.00
End Cash Position
53,397.00
53,397.00
71,925.00
115,785.00
67,099.00
Capital Expenditure
-11,196.00
-11,196.00
-14,155.00
-27,173.00
-7,199.00
Issuance of Capital Stock
500,000.00
500,000.00
--
--
--
Issuance of Debt
--
--
--
--
7,200.00
Repayment of Debt
--
--
-35,866.00
-2,056.00
-2,026.00
Repurchase of Capital Stock
-2,802.00
-2,802.00
-5,512.00
--
--
Free Cash Flow
-60,615.00
-60,615.00
10,185.00
61,340.00
25,788.00
12/31/2020 - 4/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
609.SG ABIONYX Pharma SA
1.2200
+0.33%
NAMSW NewAmsterdam Pharma Company N.V.
14.78
+3.50%
VLA.VI Valneva SE
2.2240
+4.81%
5CV.DE CureVac N.V.
4.2660
+9.61%
IFRX InflaRx N.V.
2.2300
-4.29%
SNGX Soligenix, Inc.
3.2000
-2.14%
ELAB PMGC Holdings Inc.
2.0600
-2.37%
ZEAL.CO Zealand Pharma A/S
735.00
+0.07%
CVM CEL-SCI Corporation
0.4252
+16.05%
NLSP NLS Pharmaceutics AG
2.3200
-3.73%